Phung is spearheading efforts at USA Health to enhance molecular diagnostics for cancer patients in the Gulf Coast region by establishing rapid single-gene testing as well as actionable, cost-effective next-generation sequencing (NGS) assays.
In her presentation, Phung will explore and address the gap in molecular testing in underserved communities. “Molecular diagnostics provide important genetic information for informed precision cancer care,” she said. “However, molecular testing, such as broad-panel testing, remains underutilized in oncology practices in community and small laboratory settings.”
The PMWC expects 3,000 attendees from 35 countries, including recognized leaders in precision medicine, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors.
